Bone Biologics Corporation ( BBLG) - Key Metrics
BBLG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.43 | -$0.29 | -$0.29 |
| 2026Q1 | $0 | -$0.43 | -$0.45 | -$0.45 |
| 2025Q4 | $0 | -$0.58 | -$0.61 | -$0.61 |
| 2025Q3 | $0 | -$0.37 | -$0.33 | -$0.33 |
| 2025Q2 | $0 | -$1.33 | -$0.82 | -$0.82 |
BBLG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.80 |
| 2026Q1 | 0% | -0.64 |
| 2025Q4 | 0% | -0.58 |
| 2025Q3 | 0% | -1.89 |
| 2025Q2 | 0% | -0.76 |
BBLG
Price: $0.64
52 week price:
Earnings Per Share: -1.16 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 118500
Market Capitalization: 1.2 million